Funded by the California Institute for Regenerative Medicine, UCLA’s Eli and Edythe Broad Center of Regeneration Medicine & Stem Cell Research has been awarded $2.2 million for a new stem cell gene therapy research project.

This will test the exciting new CRISPR/Cas9 genome editing technology, which could result in a treatment for Duchenne muscular dystrophy.


Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>